Aurora Spine has announced that it has received the CE mark for its ZIP minimally invasive surgery (MIS) interspinous fusion system, which—a company press release reports—is the first device to use “ZIP-LOCK” technology. The system is a posterior, non-pedicle supplemental fixation device, intended for use in the non-cervical spine (T1-S1).
According to the press release, the ZIP MIS is intended for plate fixation/attachment to the spinous process for the purpose of achieving supplemental fusion in the following conditions: degenerative disc disease, spondylolisthesis, trauma, and/or tumour. It is intended for use with bone graft material and is not intended for stand-alone use.
“This is a very significant accomplishment for the company as it moves towards commercialisation and its planned launch into the European markets.” stated Trent Northcutt, president and chief executive officer of Aurora Spine. “The CE mark also paves the way for approvals of the ZIP MIS interspinous fusion system device internationally, meeting the company’s global mandate.”
